Signed in
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
Russia's oncolytic cancer vaccine EnteroMix based on the combination of four non-pathogenic viruses able to destroy malignant cells and simultaneously activate the patient’s antitumour immunity. Over the past few years, a full cycle of pre-clinical studies were completed, confirming the effectiveness and safety of the drug.